Published in J Mol Cell Cardiol on April 01, 1976
Myocardial protection after monophosphoryl lipid A: studies of delayed anti-ischaemic properties in rabbit heart. Br J Pharmacol (1996) 0.85
Preconditioning by subinotropic doses of ouabain in the Langendorff perfused rabbit heart. J Cardiovasc Pharmacol (2010) 0.81
Cytoskeletal injury and subsarcolemmal bleb formation in dog heart during in vitro total ischemia. Am J Pathol (1988) 0.79
Monophosphoryl lipid A provides biphasic cardioprotection against ischaemia-reperfusion injury in rat hearts. Br J Pharmacol (1999) 0.78
Protection against cardiac anoxia--role and limitations of increased glycogen reserves in the isolated rat right ventricular strip. Basic Res Cardiol (1982) 0.75
The NLM Indexing Initiative. Proc AMIA Symp (2000) 11.40
Knowledge-based indexing of the medical literature: the Indexing Aid Project. J Am Soc Inf Sci (1987) 4.15
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res (1988) 3.98
Studies of acidosis in the ischaemic heart by phosphorus nuclear magnetic resonance. Biochem J (1979) 3.01
Myocardial ischaemia: can we agree on a definition for the 21st century? Cardiovasc Res (1994) 2.16
Phosphorus NMR studies on perfused heart. Biochem Biophys Res Commun (1977) 2.04
Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol (1984) 2.00
The oxygen paradox and the calcium paradox: two facets of the same problem? J Mol Cell Cardiol (1978) 1.95
Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res (1987) 1.83
Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol (1973) 1.77
Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res (1987) 1.74
Reperfusion of the ischemic myocardium. J Mol Cell Cardiol (1977) 1.74
Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am J Physiol (1999) 1.61
Ischemic contracture of the myocardium: mechanisms and prevention. Am J Cardiol (1977) 1.61
Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res (1986) 1.52
The influence of some physico-chemical factors on the biliary excretion of a series of structurally related aryl sulphate esters. Biochem Pharmacol (1969) 1.51
Is a functional sarcoplasmic reticulum necessary for preconditioning? J Mol Cell Cardiol (2000) 1.51
Oxygen deprivation and early myocardial contractile failure: a reassessment of the possible role of adenosine triphosphate. Am J Cardiol (1979) 1.48
The antiarrhythmic action of ischaemic preconditioning in rat hearts does not involve functional Gi proteins. Cardiovasc Res (1993) 1.46
Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart. J Thorac Cardiovasc Surg (1989) 1.43
Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion. J Thorac Cardiovasc Surg (1988) 1.43
Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol. Circ Res (1984) 1.39
Harvesting hearts for long-term preservation. Detrimental effects of initial hypothermic infusion of cardioplegic solutions. J Thorac Cardiovasc Surg (1990) 1.38
Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol (1987) 1.35
The isolated blood and perfusion fluid perfused heart. Pharmacol Res (2000) 1.34
Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion? Acta Physiol Scand Suppl (1986) 1.26
Hypothermic arrest and potassium arrest: metabolic and myocardial protection during elective cardiac arrest. Circ Res (1975) 1.25
Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol (1989) 1.23
The role of glucose in the survival and 'recovery' of the anoxic isolated perfused rat heart. Biochem J (1972) 1.20
The "border zone" in evolving myocardial infarction: controversy or confusion? Am J Cardiol (1981) 1.14
Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in the rat heart. Possible evidence of endothelial damage. J Thorac Cardiovasc Surg (1989) 1.13
Creatine kinase isoenzymes: their separation and quantitation. Cardiovasc Res (1977) 1.12
Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase. Biochem J (1973) 1.12
Myocardial protection during ischemic cardiac arrest. A possible hazard with calcium-free cardioplegic infusates. J Thorac Cardiovasc Surg (1977) 1.09
Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc Res (1993) 1.08
Free radicals and reperfusion-induced arrhythmias: protection by spin trap agent PBN in the rat heart. Circ Res (1987) 1.08
Regulation of sarcolemmal Na(+)/H(+) exchanger activity by angiotensin II in adult rat ventricular myocytes: opposing actions via AT(1) versus AT(2) receptors. Circ Res (1999) 1.07
Ultrastructural damage associated with reoxygenation of the anoxic myocardium. J Mol Cell Cardiol (1975) 1.06
Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis. J Mol Cell Cardiol (1989) 1.04
Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest. Circulation (1976) 1.03
The relationship of ischemic contracture of vascular reperfusion in the isolated rat heart. J Mol Cell Cardiol (1980) 1.02
Enzyme release during myocardial anoxia: a study of metabolic protection. J Mol Cell Cardiol (1975) 1.01
Ischemia-induced and reperfusion-induced arrhythmias: importance of heart rate. Am J Physiol (1989) 1.00
Recovery from cardiac bypass and elective cardiac arrest. The metabolic consequences of various cardioplegic procedures in the isolated rat heart. Circ Res (1974) 0.99
The calcium paradox: metabolic, electrophysiological, contractile and ultrastructural characteristics in four species. Eur J Cardiol (1978) 0.99
Cold cardioplegia or continuous coronary perfusion? Report on preliminary clinical experience as assessed cytochemically. J Thorac Cardiovasc Surg (1977) 0.98
Myocardial protection during ischemic cardiac arrest. The importance of magnesium in cardioplegic infusates. J Thorac Cardiovasc Surg (1978) 0.97
Temporal and spatial characteristics of evolving cell injury during regional myocardial ischemia in the dog: the "border zone" controversy. J Am Coll Cardiol (1983) 0.96
Effects of anoxic or oxygenated reperfusion in globally ischemic, isovolumic, perfused rat hearts. Am J Pathol (1985) 0.96
Brain death-induced impairment of cardiac contractile performance can be reversed by explantation and may not preclude the use of hearts for transplantation. Circ Res (1992) 0.96
Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: verapamil infusion in dogs with small myocardial infarcts. Am J Cardiol (1983) 0.94
Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart. J Mol Cell Cardiol (1987) 0.94
Developments in cardioprotection: "polarized" arrest as an alternative to "depolarized" arrest. Ann Thorac Surg (1999) 0.94
Diabetes and the survival and recovery of the anoxic myocardium. J Mol Cell Cardiol (1975) 0.94
The metabolic fate and elimination of streptozotocin. Biochem Soc Trans (1975) 0.94
"Dose"-dependency and temporal characteristics of protection by ischaemic preconditioning against ischaemia-induced arrhythmias in rat hearts. J Mol Cell Cardiol (1993) 0.93
Verapamil and the calcium paradox. J Mol Cell Cardiol (1980) 0.93
NMR-visible ATP and Pi in normoxic and reperfused rat hearts: a quantitative study. Am J Physiol (1991) 0.93
The effect of an isovolumic left ventricle on the coronary vascular competence during reflow after global ischemia in the rat heart. Circ Res (1981) 0.92
The temperature dependence of the calcium paradox: enzymatic, functional and morphological correlates of cellular injury. J Mol Cell Cardiol (1983) 0.92
Reperfusion-induced arrhythmias and free radicals: studies in the rat heart with DMPO. J Cardiovasc Pharmacol (1987) 0.91
Preconditioning and reperfusion arrhythmias in the isolated rat heart: true protection or temporal shift in vulnerability? Cardiovasc Res (1993) 0.91
Comparison of the multiple deoxyribonucleic acid-dependent ribonucleic acid polymerase forms of whole rat liver and a minimal-deviation rat hepatoma cell line. Biochem J (1972) 0.91
Reperfusion arrhythmias: dose-related protection by anti-free radical interventions. Am J Physiol (1989) 0.90
Particle-induced coronary vasoconstriction during cardioplegic infusion. Characterization and possible mechanisms. J Thorac Cardiovasc Surg (1985) 0.90
Role of protein kinase C in ischemic preconditioning: player or spectator? Circ Res (1996) 0.90
Reperfusion-induced arrhythmias: mechanisms of protection by glucose and mannitol. Am J Physiol (1988) 0.90
Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia. Cardiovasc Res (1992) 0.89
Characterization of the lateral interface between normal and ischemic tissue in the canine heart during evolving myocardial infarction. Am J Cardiol (1981) 0.89
The synthesis of [14C] streptozotocin and its distribution and excretion in the rat. Biochem J (1974) 0.89
Cardioplegia and slow calcium-channel blockers. Studies with verapamil. J Thorac Cardiovasc Surg (1983) 0.88
Extracellular volume and transsarcolemmal proton movement during ischemia and reperfusion: a 31P NMR spectroscopic study of the isovolumic rat heart. NMR Biomed (1993) 0.88
Calcium antagonists and hypothermia: the temperature dependency of the negative inotropic and anti-ischemic properties of verapamil in the isolated rat heart. Circulation (1984) 0.88
Slow calcium channel blockers and the calcium paradox: comparative studies in the rat with seven drugs. J Mol Cell Cardiol (1983) 0.87
Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel. Cardioscience (1991) 0.87
Na+/H+ exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation (1997) 0.86
Protection of the pediatric myocardium. Differential susceptibility to ischemic injury of the neonatal rat heart. J Thorac Cardiovasc Surg (1987) 0.86
Free radicals and cardioplegia: allopurinol and oxypurinol reduce myocardial injury following ischemic arrest. Ann Thorac Surg (1987) 0.86
Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats. J Cardiovasc Pharmacol (1993) 0.86
Regional myocardial ischemia: characterization of temporal, transmural and lateral flow interfaces in the porcine heart. Can J Cardiol (1986) 0.86
Effects of R-56865 on transient inward current, Na(+)-Ca2+ exchange, and Ca2+ release from SR in cardiac myocytes. Am J Physiol (1994) 0.85
Ischemia- and reperfusion-induced arrhythmias: beneficial actions of nifedipine. J Cardiovasc Pharmacol (1987) 0.85
Protection of the myocardium during ischemic arrest: possible toxicity of carnitine in cardioplegic solutions. Thorac Cardiovasc Surg (1980) 0.85
The preparation and characterization of a series of 35S-labelled aryl sulphate esters for metabolic studies. Biochem Pharmacol (1969) 0.85
Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat. Circulation (1992) 0.85
Myocardial protection during ischemic cardiac arrest. Possible deleterious effects of glucose and mannitol in coronary infusates. J Thorac Cardiovasc Surg (1978) 0.85
Ischaemic preconditioning and contractile function: studies with normothermic and hypothermic global ischaemia. J Mol Cell Cardiol (1992) 0.84
Protection of the ischemic myocardium. Ultrastructural, enzymatic, and functional assessment of the efficacy of various cardioplegic infusates. J Thorac Cardiovasc Surg (1978) 0.84
N-acetylation of drugs. Pharmacogenetic studies in rabbits selected for their acetylator characteristics. Drug Metab Dispos (1976) 0.84
The influence of the no-reflow phenomenon on reperfusion and reoxygenation damage and enzyme release from anoxic and ischaemic isolated rat hearts. J Mol Cell Cardiol (1984) 0.84
Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart. Circulation (1992) 0.84
Na+/H+ exchanger inhibitor HOE-642 improves cardioplegic myocardial preservation under both normothermic and hypothermic conditions. Circulation (1997) 0.84